KEGG   DRUG: Elbasvir - grazoprevir mixtHelp
Entry
D10778            Mixture   Drug                                   

Name
Elbasvir - grazoprevir mixt;
Zepatier (TN)
Product
Component
Elbasvir [DR:D10625], Grazoprevir hydrate [DR:D10639]
Remark
ATC code: J05AP54
Product: D10778<US>
Efficacy
Antiviral
  Disease
Chronic hepatitis C [DS:H00413]
Comment
treatment of chronic hepatitis C virus (HCV) genotypes 1 or 4 infection
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AP Antivirals for treatment of HCV infections
     J05AP54 Elbasvir and grazoprevir
      D10778  Elbasvir - grazoprevir mixt <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-hepatitis C (HCV) Agents, Direct Acting
   Elbasvir/Grazoprevir
    D10778  Elbasvir - grazoprevir mixt
Antiinfectives [br08350.html]
 Antivirals
  D10778
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D10778
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10778
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10778
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and germline mutations
  D10778
BRITE hierarchy
Other DBs
PubChem: 313046636
ChEBI: 132973
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system